Showing results (1-10 of 334) with videos related to
Sort By:
Pageof 34
Current Opinion in Hematology|October 8, 2019
The cause and pathogenesis of hemolytic transfusion reactions in sickle-cell diseaseFrance PirenneHematology. American Society of Hematology. Education Program|December 6, 2015
Maintenance therapy for multiple myeloma in the era of novel agentsThierry FaconHematology. American Society of Hematology. Education Program|December 9, 2023
Alloimmunization and hyperhemolysis in sickle cell diseaseFrance Pirenne, Corinne PondarréBlood|May 5, 2018
How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactionsFrance Pirenne, Karina YazdanbakhshVox Sanguinis|February 9, 2026
Patient blood management and surgery: Impact of new surgical techniques on transfusion needsFrancois Ansart, France PirenneBest Practice & Research. Clinical Haematology|December 12, 2007
Frontline treatment in multiple myeloma patients not eligible for stem-cell transplantationThierry Facon, Stéphane DarreHematology. American Society of Hematology. Education Program|December 4, 2018
Treatment approach for the older, unfit patient with myeloma from diagnosis to relapse: perspectives of a European hematologistThierry Facon, Kenneth AndersonHematology. American Society of Hematology. Education Program|December 10, 2021
How to avoid the problem of erythrocyte alloimmunization in sickle cell diseaseFrance Pirenne, Aline Floch, Anoosha HabibiThe Lancet. Haematology|April 15, 2023
Alloimmunisation against red blood cells in sickle cell disease: transfusion challenges in high-income and low-income countriesFrance Pirenne, Aline Floch, Saliou DiopLeukemia|May 4, 2018
Front-line therapies for elderly patients with transplant-ineligible multiple myeloma and high-risk cytogenetics in the era of novel agentsHerve Avet-Loiseau, Thierry FaconPageof 34